Published in Cancer on December 01, 2007
Economic burden of cancer in the United States: estimates, projections, and future research. Cancer Epidemiol Biomarkers Prev (2011) 1.82
Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003. Value Health (2011) 1.22
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy. BMC Health Serv Res (2011) 0.98
The lung cancer exercise training study: a randomized trial of aerobic training, resistance training, or both in postsurgical lung cancer patients: rationale and design. BMC Cancer (2010) 0.97
The cost of treating advanced non-small cell lung cancer: estimates from the chinese experience. PLoS One (2012) 0.94
Cost-of-Illness Trend of Thyroid Gland Disease in Korea. Endocrinol Metab (Seoul) (2014) 0.85
Autoantibodies against insulin-like growth factor‑binding protein-2 as a serological biomarker in the diagnosis of lung cancer. Int J Oncol (2012) 0.84
Hyaluronan synthesis inhibitor supplements the inhibitory effects of zoledronic acid on bone metastasis of lung cancer. Clin Exp Metastasis (2013) 0.80
CD24+/CD38- as new prognostic marker for non-small cell lung cancer. Multidiscip Respir Med (2013) 0.79
Anti-tumor activity of fenretinide complexed with human serum albumin in lung cancer xenograft mouse model. Oncotarget (2014) 0.76
Adaptation of a chemosensitivity assay to accurately assess pemetrexed in ex vivo cultures of lung cancer. Cancer Biol Ther (2012) 0.75
Establishment of a new method, transcription-reverse transcription concerted reaction, for detection of plasma hnRNP B1 mRNA, a biomarker of lung cancer. J Cancer Res Clin Oncol (2008) 0.75
Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med (2005) 16.70
The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med (2007) 12.23
Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst (2011) 10.29
Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst (2013) 8.75
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst (2005) 8.36
Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst (2008) 7.85
Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst (2002) 6.64
Incidence and mortality of hip fractures in the United States. JAMA (2009) 6.05
Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. JAMA (2010) 5.78
Forecasting the effects of obesity and smoking on U.S. life expectancy. N Engl J Med (2009) 5.64
The gap gets bigger: changes in mortality and life expectancy, by education, 1981-2000. Health Aff (Millwood) (2008) 4.94
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med (2009) 4.60
Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst (2008) 4.53
Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med (2004) 4.49
Trends in the prevalence and mortality of cognitive impairment in the United States: is there evidence of a compression of cognitive morbidity? Alzheimers Dement (2008) 4.00
Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst (2004) 3.74
Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Med Care (2005) 3.53
Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med (2009) 3.34
Health plan policies and programs for colorectal cancer screening: a national profile. Am J Manag Care (2004) 3.27
Patient time costs associated with cancer care. J Natl Cancer Inst (2007) 2.90
Surveying physicians: do components of the "Total Design Approach" to optimizing survey response rates apply to physicians? Med Care (2002) 2.68
Insurance status and the use of guideline therapy in the treatment of selected cancers. J Clin Oncol (2005) 2.67
Current and future utilization of services from medical oncologists. J Clin Oncol (2008) 2.65
Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev (2011) 2.62
Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes. Ann Intern Med (2005) 2.60
Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst (2010) 2.59
Increased spending on health care: how much can the United States afford? Health Aff (Millwood) (2003) 2.41
Prescription drug spending trends in the United States: looking beyond the turning point. Health Aff (Millwood) (2008) 2.37
Productivity costs of cancer mortality in the United States: 2000-2020. J Natl Cancer Inst (2008) 2.23
Mortality reduction among pneumonia patients still substantial despite the impact of coding changes. Am J Med (2013) 2.14
Breast cancer incidence rates in U.S. women are no longer declining. Cancer Epidemiol Biomarkers Prev (2011) 2.06
Age-conditional probabilities of developing cancer. Stat Med (2003) 2.03
Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer. J Gen Intern Med (2004) 1.97
Estimating patient time costs associated with colorectal cancer care. Med Care (2005) 1.94
A national framework for cancer surveillance in the United States. Cancer Causes Control (2005) 1.89
Improving the quality of surveys of physicians and medical groups: a research agenda. Eval Health Prof (2012) 1.84
Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. J Natl Cancer Inst (2008) 1.84
Estimates and projections of value of life lost from cancer deaths in the United States. J Natl Cancer Inst (2008) 1.83
Explaining racial differences in prostate cancer mortality. Cancer (2012) 1.82
Comparison of approaches for estimating incidence costs of care for colorectal cancer patients. Med Care (2009) 1.76
Projections of the costs associated with colorectal cancer care in the United States, 2000-2020. Health Econ (2008) 1.72
Trends in colorectal cancer test use in the medicare population, 1998-2005. Am J Prev Med (2009) 1.68
A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010. Obstet Gynecol (2012) 1.67
Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women. Cancer Epidemiol Biomarkers Prev (2010) 1.66
Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source? Med Care (2009) 1.62
Increasing health insurance costs and the decline in insurance coverage. Health Serv Res (2005) 1.61
Changing patterns in breast cancer incidence trends. J Natl Cancer Inst Monogr (2006) 1.61
Impact of insurance and supply of health professionals on coverage of treatment for hypertension in Mexico: population based study. BMJ (2007) 1.60
Costs of cancer care in the USA: a descriptive review. Nat Clin Pract Oncol (2007) 1.54
Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings. J Clin Oncol (2002) 1.52
Challenges in building disease-based national health accounts. Med Care (2009) 1.50
Are physicians' recommendations for colorectal cancer screening guideline-consistent? J Gen Intern Med (2010) 1.44
Trends in medical spending by age, 1963-2000. Health Aff (Millwood) (2004) 1.42
Comparison of trends in US health-related quality of life over the 2000s using the SF-6D, HALex, EQ-5D, and EQ-5D visual analog scale versus a broader set of symptoms and impairments. Med Care (2014) 1.41
The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testing. Stat Methods Med Res (2004) 1.39
Cost-effectiveness of coronary MDCT in the triage of patients with acute chest pain. AJR Am J Roentgenol (2008) 1.37
Marked reduction in 30-day mortality among elderly patients with community-acquired pneumonia. Am J Med (2011) 1.36
Cervical cancer screening in the United States and the Netherlands: a tale of two countries. Milbank Q (2012) 1.35
Clinical outcomes and cost-effectiveness of coronary computed tomography angiography in the evaluation of patients with chest pain. J Am Coll Cardiol (2009) 1.34
Disability and the future of Medicare. N Engl J Med (2003) 1.32
Racial differences in the receipt of bowel surveillance following potentially curative colorectal cancer surgery. Health Serv Res (2003) 1.27
Increased spending on health care: long-term implications for the nation. Health Aff (Millwood) (2009) 1.23
The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis. Cancer (2005) 1.22
Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer. Am J Epidemiol (2012) 1.21
Trends in thrombolytic use for ischemic stroke in the United States. J Hosp Med (2010) 1.19
The ACO rules--striking the balance between participation and transformative potential. N Engl J Med (2011) 1.18
Cure fraction estimation from the mixture cure models for grouped survival data. Stat Med (2004) 1.18
A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends. J Natl Cancer Inst Monogr (2006) 1.15
Health care costing: data, methods, current applications. Med Care (2009) 1.13
The impact of symptoms and impairments on overall health in US national health data. Med Care (2008) 1.11
Improved survival time: what can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer? Cancer (2008) 1.06
Sustained lower rates of breast cancer in the United States. Breast Cancer Res Treat (2008) 1.05
Modeling cancer natural history, epidemiology, and control: reflections on the CISNET breast group experience. J Natl Cancer Inst Monogr (2006) 1.03
Surveillance endoscopy does not improve survival for patients with local and regional stage colorectal cancer. Cancer (2007) 1.02
A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics (2009) 1.01
Health limitations and quality of life associated with cancer and other chronic diseases by phase of care. Med Care (2007) 1.01
Girls' education and HIV risk: evidence from Uganda. J Health Econ (2013) 1.01
Cancer outcomes research. J Natl Cancer Inst Monogr (2004) 0.99
Improving colorectal cancer screening through research in primary care settings. Med Care (2008) 0.98
Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States. J Clin Oncol (2013) 0.97
Physician recommendations for follow-up of positive fecal occult blood tests. Med Care Res Rev (2005) 0.97
Adoption and spread of new imaging technology: a case study. Health Aff (Millwood) (2009) 0.93
Association of regional variation in primary care physicians' colorectal cancer screening recommendations with individual use of colorectal cancer screening. Prev Chronic Dis (2007) 0.92
Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies. Ann Intern Med (2016) 0.92
Using a composite index of socioeconomic status to investigate health disparities while protecting the confidentiality of cancer registry data. Cancer Causes Control (2013) 0.91
Overview of breast cancer collaborative stage data items--their definitions, quality, usage, and clinical implications: a review of SEER data for 2004-2010. Cancer (2014) 0.91
US trends in quality-adjusted life expectancy from 1987 to 2008: combining national surveys to more broadly track the health of the nation. Am J Public Health (2013) 0.91
Treatment options for localized prostate cancer: quality-adjusted life years and the effects of lead-time. Urology (2004) 0.89
Inventory of data sources for estimating health care costs in the United States. Med Care (2009) 0.89
Predicting the absolute risk of dying from colorectal cancer and from other causes using population-based cancer registry data. Stat Med (2011) 0.89
Disability forecasts and future Medicare costs. Front Health Policy Res (2004) 0.88
Overuse of antidepressants in a nationally representative adult patient population in 2005. Psychiatr Serv (2011) 0.88
Trends in abnormal cancer screening results in the United States of America. J Med Screen (2007) 0.88
The value of coronary heart disease care for the elderly: 1987-2002. Health Aff (Millwood) (2007) 0.88
Productivity savings from colorectal cancer prevention and control strategies. Am J Prev Med (2011) 0.88
Modeling the impact of population screening on breast cancer mortality in the United States. Breast (2011) 0.87
Implications of new colorectal cancer screening technologies for primary care practice. Med Care (2008) 0.87
The impact of changes in hormone therapy on breast cancer incidence in the US population. Cancer Causes Control (2009) 0.85
Medical spending differences in the United States and Canada: the role of prices, procedures, and administrative expenses. Inquiry (2010) 0.84
Trends in mortality and medical spending in patients hospitalized for community-acquired pneumonia: 1993-2005. Med Care (2010) 0.84